From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Semaglutide, tirzepatide, and liraglutide are FDA-approved GLP-1 peptides that are clinically safe and effective for diabetes and weight management
A few careful steps keep BAC water effective and safe for longer: All medical vials should be kept in a closed cabinet or medicine box
Starting at a low dose and gradually increasing over weeks helps minimize digestive side effects and gives your body time to adjust
Gastrointestinal Research Models BPC-157 has been frequently studied in gastrointestinal contexts, including in models simulating ulcerative or inflammatory conditions
